The paper's citation list
No. | The paper's citation list |
|---|
1 | A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer. 2021;11: doi: 10.1038/s41598-021-93107-w |
2 | Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies. 2024;5:1110 doi: 10.37349/etat.2024.00266 |
3 | Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?. 2021;13:327 doi: 10.3390/cancers13020327 |
4 | PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies. 2023;33:6502 doi: 10.1007/s00330-023-09619-8 |
5 | Critical Developments in Cancer Immunotherapy. 2024;265 doi: 10.4018/979-8-3693-3976-3.ch008 |
